Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats

Molecular and Cellular Biochemistry

Volumn 388, Issue 1-2, 2014, Pages 95-111

  Sharma, Vikram ^a,b   Tikoo, Kulbhushan ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b Marine Biology and Ecology Research Centre (MBERC)   (United Kingdom)

Author keywords

Calgranulin A; Calgranulin B; Diabetic nephropathy; MALDI TOF TOF; Proteomics; Streptozotocin; Urine

Indexed keywords

ALPHA-GLOBULINS; ANIMALS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CADHERINS; CALGRANULIN A; CALGRANULIN B; COLLAGEN; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBRONECTINS; KIDNEY; MALE; MATRIX METALLOPROTEINASE 13; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STREPTOZOCIN;

EID: 84893827881     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1902-5     Document Type: Article

References (60)

1. Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP (2005) Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 5:2648-2655 (Pubitemid 40966492)
2. Krolewski AS, Warram JH (1995) Genetic susceptibility to diabetic kidney disease: an update. J Diabetes Complications 9:277-281
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462 (Pubitemid 23335891)
4. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860
5. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
6. Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS (2007) Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol 2:461-469
7. Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH (2001) Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24:1560-1566 (Pubitemid 33716449)
8. Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413-1418 (Pubitemid 27300386)
9. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426 (Pubitemid 32681484)
10. Matheson A, Willcox MD, Flanagan J, Walsh BJ (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 26:150-171
11. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P (2004) Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65:323-332 (Pubitemid 38037520)
12. Cutillas PR, Chalkley RJ, Hansen KC, Cramer R, Norden AG, Waterfield MD, Burlingame AL, Unwin RJ (2004) The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol 287:F353-F364 (Pubitemid 39095948)
13. Thongboonkerd V, McLeish KR, Arthur JM, Klein JB (2002) Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int 62:1461-1469
14. Argiles A, Siwy J, Duranton F, Gayrard N, Dakna M, Lundin U, Osaba L, Delles C, Mourad G, Weinberger KM, Mischak H (2013) CKD273, a new proteomics classifier assessing CKD and its prognosis. PLoS One 8:e62837. doi: 10.1371/journal.pone.0062837
15. Fugmann T, Borgia B, Revesz C, Godo M, Forsblom C, Hamar P, Holthofer H, Neri D, Roesli C (2011) Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy. Kidney Int 80:272-281
16. Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB (2009) Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol 20:2065-2074
17. Cho WC, Yip TT, Chung WS, Leung AW, Cheng CH, Yue KK (2006) Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. J Cell Biochem 99:256-268 (Pubitemid 44297969)
18. Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, Dakshinamurthy KV, Roberts CT Jr, Nagalla SR (2007) Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 30:629-637 (Pubitemid 46354345)
19. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC, Knowler WC, Monroy M, Libermann TA, Karumanchi SA, Thadhani R (2007) Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 30:638-643 (Pubitemid 46354346)
20. Overgaard AJ, Hansen HG, Lajer M, Pedersen L, Tarnow L, Rossing P, McGuire JN, Pociot F (2010) Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy. Proteome Sci 8:4
21. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, Jankowski J, Mischak H (2007) Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 18:1057-1071 (Pubitemid 46536892)
22. Thongboonkerd V (2011) Study of diabetic nephropathy in the proteomic era. Contrib Nephrol 170:172-183
23. Pesic I, Stefanovic V, Muller GA, Muller CA, Cukuranovic R, Jahn O, Bojanic V, Koziolek M, Dihazi H (2011) Identification and validation of six proteins as marker for endemic nephropathy. J Proteomics 74:1994-2007
24. Tilton RG, Haidacher SJ, Lejeune WS, Zhang X, Zhao Y, Kurosky A, Brasier AR, Denner L (2007) Diabetes-induced changes in the renal cortical proteome assessed with two-dimensional gel electrophoresis and mass spectrometry. Proteomics 7:1729-1742 (Pubitemid 46841832)
25. Ramachandra Rao SP, Wassell R, Shaw MA, Sharma K (2007) Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake. Am J Physiol Renal Physiol 292:F1182-F1189
26. Li Z, Zhang H, Dong X, Burczynski FJ, Choy P, Yang F, Liu H, Li P, Gong Y (2010) Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats. Biochem Cell Biol 88:635-648
27. Zhang D, Yang H, Kong X, Wang K, Mao X, Yan X, Wang Y, Liu S, Zhang X, Li J, Chen L, Wu J, Wei M, Yang J, Guan Y (2011) Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am J Physiol Endocrinol Metab 300:E287-E295
28. Tikoo K, Tripathi DN, Kabra DG, Sharma V, Gaikwad AB (2007) Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53. FEBS Lett 581:1071-1078 (Pubitemid 46282743)
29. Allcock GH, Hukkanen M, Polak JM, Pollock JS, Pollock DM (1999) Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats. J Am Soc Nephrol 10:2283-2289 (Pubitemid 29501460)
30. Shevchenko A, Jensen ON, Podtelejnikov AV, Sagliocco F, Wilm M, Vorm O, Mortensen P, Shevchenko A, Boucherie H, Mann M (1996) Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci USA 93:14440-14445 (Pubitemid 26418985)
31. da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
32. da Huang W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13
33. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39:D561-D568
34. Tikoo K, Singh K, Kabra D, Sharma V, Gaikwad A (2008) Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic Res 42:397-404
35. Roy S, Sala R, Cagliero E, Lorenzi M (1990) Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 87:404-408 (Pubitemid 20033079)
36. Jonas E, Jackle-Meyer I, Szukics B, Stolte H (1996) Urinary fibronectin excretion in streptozotocin-diabetic rats. Eur J Clin Chem Clin Biochem 34:485-492 (Pubitemid 26232360)
37. Lenz O, Elliot SJ, Stetler-Stevenson WG (2000) Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11:574-581 (Pubitemid 30115088)
38. Surse VM, Gupta J, Tikoo K (2011) Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats. J Mol Endocrinol 46:245-254
39. El Mesallamy HO, Ahmed HH, Bassyouni AA, Ahmed AS (2012) Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy. Clin Biochem 45:646-650. doi: 10.1016/j.clinbiochem.2012.02.021
40. Roy AK, Leonard S (1973) Androgen-dependent synthesis of 2u globulin in diabetic rats: the role of insulin. J Endocrinol 57:327-328
41. Murty CV, Demyan WF, Chatterjee B, Roy AK (1986) Partial reversal of alpha 2u globulin gene expression by thyroxine in the liver of diabetic rats. Biochemistry 25:4376-4380 (Pubitemid 16054248)
42. Bouma G, Coppens JM, Lam-Tse WK, Luini W, Sintnicolaas K, Levering WH, Sozzani S, Drexhage HA, Versnel MA (2005) An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes. Clin Exp Immunol 141:509-517 (Pubitemid 41075875)
43. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Ogawa Y, Imamaki H, Kawanishi T, Ishii A, Koga K, Mori KP, Kato Y, Sugawara A, Nakao K (2012) Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 55(8):2256-2266
44. van Lith M, Karala AR, Bown D, Gatehouse JA, Ruddock LW, Saunders PT, Benham AM (2007) A developmentally regulated chaperone complex for the endoplasmic reticulum of male haploid germ cells. Mol Biol Cell 18:2795-2804 (Pubitemid 47235288)
45. Matsushita M, Yamadori T, Kato S, Takemoto Y, Inazawa J, Baba Y, Hashimoto S, Sekine S, Arai S, Kunikata T, Kurimoto M, Kishimoto T, Tsukada S (1998) Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK). Biochem Biophys Res Commun 245:337-343 (Pubitemid 28418501)
46. Yamadori T, Baba Y, Matsushita M, Hashimoto S, Kurosaki M, Kurosaki T, Kishimoto T, Tsukada S (1999) Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein. Proc Natl Acad Sci USA 96:6341-6346 (Pubitemid 29256667)
47. Wiltshire C, Matsushita M, Tsukada S, Gillespie DA, May GH (2002) A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem J 367:577-585 (Pubitemid 35305698)
48. de Moraes RV, Oliveira DT, Landman G, de Carvalho F, Caballero O, Nonogaki S, Nishimoto I, Kowalski LP (2007) E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer. Head Neck 30(1):85-92 (Pubitemid 351158325)
49. Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y (2009) Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev 25:232-241
50. Banks RE, Porter WH, Whelan P, Smith PH, Selby PJ (1995) Soluble forms of the adhesion molecule E-cadherin in urine. J Clin Pathol 48:179-180
51. Shen SH, Bastien L, Posner BI, Chretien P (1991) A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 352:736-739 (Pubitemid 21912421)
52. Matthews RJ, Bowne DB, Flores E, Thomas ML (1992) Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 12:2396-2405
53. Yi TL, Cleveland JL, Ihle JN (1992) Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 12:836-846
54. Imani F, Rager KJ, Catipovic B, Marsh DG (1997) Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem 272:7927-7931 (Pubitemid 27137354)
55. Cuevas B, Lu Y, Watt S, Kumar R, Zhang J, Siminovitch KA, Mills GB (1999) SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem 274:27583-27589 (Pubitemid 29458004)
56. Yu Z, Su L, Hoglinger O, Jaramillo ML, Banville D, Shen SH (1998) SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 273:3687-3694 (Pubitemid 28109796)
57. Oriente F, Iovino S, Cabaro S, Cassese A, Longobardi E, Miele C, Ungaro P, Formisano P, Blasi F, Beguinot F (2011) Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. Diabetes 60:138-147
58. Xu E, Charbonneau A, Rolland Y, Bellmann K, Pao L, Siminovitch KA, Neel BG, Beauchemin N, Marette A (2012) Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance. Diabetes 61(8):1949-1958
59. Ajiro K, Scoltock AB, Smith LK, Ashasima M, Cidlowski JA (2010) Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivo. Cell Death Differ 17:984-993
60. Knepper MA (2002) Proteomics and the kidney. J Am Soc Nephrol 13:1398-1408 (Pubitemid 34441423)